Showing 5071-5080 of 5693 results for "".
- CooperVision Seeks Proposals for Science and Technology Awardshttps://modernod.com/news/coopervision-seeks-proposals-for-science-and-technology-awards/2477387/CooperVision is now accepting submissions for its
- CDC Updates Guidance for Public Gatheringshttps://modernod.com/news/cdc-updates-guidance-for-coronavirus-disease-2019/2477385/On Sunday, the Centers for Disease Control and Prevention (CDC) updated its guidance regarding public gatherings during the COVID-19 outbreak. The CDC now recommends that for the next 8 weeks, organizers (whether groups or individuals) cancel or postpone in-person events that consist of 50
- The Vision Council Examines Consumers’ Attitudes About COVID-19 in a Survey for Its Membershttps://modernod.com/news/the-vision-council-examines-consumers-attitudes-about-covid-19-in-a-survey-for-its-members/2477382/The Vision Council released a new COVID-19 Optical Impact consumer survey. Conducted by The Vision Council’s research team in February, the study surveyed more than 10,000 adults across the U.S. and was designed to measure respondents’ level of concern over exposure to COVID-19, including measure
- Top Contact Lens Experts Dispel Misinformation Regarding Coronavirushttps://modernod.com/news/top-contact-lens-experts-dispel-misinformation-regarding-coronavirus/2477381/Three of the world’s most published researchers in eye health are responding to misinformation circulating regarding contact lens and spectacles/glasses wear amidst Novel Coronavirus/COVID-19 pandemic. Lyndon Jones, director of the Centre for Ocular Research & Education (CORE) at the U
- ARVO Annual Meeting Cancelledhttps://modernod.com/news/arvo-annual-meeting-cancelled/2477380/Due to the COVID-19 outbreak, the Board of Trustees at The Association for Research in Vision and Ophthalmology (ARVO) has decided to cancel its annual meeting, scheduled to take place May 1–7 in Baltimore. The ARVO organizers released an emailed statement to its membership outlining the d
- Alcon Announces European Launch of Vivity Presbyopia-Correcting IOL With X-WAVE Technologyhttps://modernod.com/news/alcon-announces-european-launch-of-vivity-presbyopia-correcting-iol-with-x-wave-technology/2477377/Alcon announced that the AcrySof IQ Vivity IOL is now commercially available in select European markets, with additional countries to follow throughout 2020. The latest innovation in Alcon’s portfolio of presbyopia-correcting IOLs (PC-IOLs), Vivity is the first-of-its-kind, extended range
- Aldeyra Announces Strategic Prioritization of Late-Stage Clinical Pipeline in Ocular Diseasehttps://modernod.com/news/aldeyra-announces-strategic-prioritization-of-late-stage-clinical-pipeline-in-ocular-disease/2477378/Aldeyra Therapeutics announced strategic prioritization of late-stage ocular disease programs in allergic conjunctivitis, dry eye disease, and proliferative vitreoretinopathy. In conjunction with the strategic prioritization, Aldeyra appointed ophthalmology drug development expert James A. Gow, M
- Nicox Updates on Zerviate Progress in China and Expands the Countries of its Agreement with Ocumension Therapeuticshttps://modernod.com/news/nicox-updates-on-zerviate-progress-in-china-and-expands-the-countries-of-its-agreement-with-ocumension-therapeutics/2477370/Nicox SA announced that it has amended its March 2019 license agreement with Ocumension Therapeutics granting Ocumension exclusive rights to develop and commercialize Zerviate (cetirizine ophthalmic solution), 0.24% for the treatment of allergic conjunctivitis in
- AAD Annual Meeting Becomes Latest Casualty of COVID-19 Outbreakhttps://modernod.com/news/aad-annual-meeting-becomes-latest-casualty-of-covid-19-outbreak/2477371/The American Academy of Dermatology (AAD) annual meeting became the latest casualty of the COVID-19 outbreak, with the conference cancelled on Tuesday. The meeting was scheduled to be held from March 20 to 24
- Sight Sciences Announces Publication of First-Ever Multicenter MIGS study in Childhood Glaucomahttps://modernod.com/news/sight-sciences-announces-publication-of-first-ever-multicenter-migs-study-in-childhood-glaucoma/2477366/Sight Sciences announced that positive outcomes from a new multicenter study of one of the OMNI Surgical System’s predecessor devices, TRAB360, were published in the